US 11939340
CDK inhibitors and their use as pharmaceuticals
granted A61KA61K45/06A61P
Quick answer
US patent 11939340 (CDK inhibitors and their use as pharmaceuticals) held by Prelude Therapeutics, Incorporated expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K45/06, A61P, A61P15/08, A61P35/00